Kardiofit 5 mg Tablets (Benazepril Hydrochloride) by Reyyaansh

Kardiofit 5 mg Tablets by Reyyaansh are designed to support cardiovascular health in dogs and cats through benazepril hydrochloride, a well-established angiotensin-converting enzyme (ACE) inhibitor. Used in the treatment of chronic heart failure, systemic hypertension, and kidney-related proteinuria, these tablets improve hemodynamic stability by reducing blood pressure and cardiac workload. The formulation is veterinary-approved and well-tolerated, offering safe, effective, and long-term management of cardiac and renal conditions.

Usage:

Target Species: Dogs and cats

Indications: For the treatment of congestive heart failure, systemic hypertension, and proteinuria associated with chronic kidney disease

Application: Oral administration, under veterinary supervision

Dosage:

• Dogs: 0.25–0.5 mg/kg once daily

• Cats: 0.5 mg/kg once daily
  (Adjustable based on clinical response and veterinarian’s recommendation)

Method: Administer directly or with a small amount of food; tablet should not be split unless directed

Frequency: Once daily, long-term or as prescribed

Features and Benefits:

• 5 mg benazepril hydrochloride per tablet: Reliable ACE inhibition for cardiovascular and renal support

• Effective in both dogs and cats: Versatile treatment for multiple companion species

• Reduces cardiac workload: Helps manage congestive heart failure and high blood pressure

• Supports kidney health: Controls proteinuria in cases of chronic kidney disease

• Veterinary-grade formulation: Designed for optimal tolerability and clinical outcomes